GB00BJQTGV64 - A2PF80 (XLON)
DIACEUTICS PLC Share
1,24 GBP
Current Prices from DIACEUTICS PLC
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
London |
DXRX.L
|
GBX
|
23.12.2024 11:56
|
123,55 GBX
| 125,50 GBX | -1,55 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
-1,55 % | 3,39 % | 7,34 % | -7,80 % | 2,96 % | 37,28 % | 21,72 % |
Company Profile for DIACEUTICS PLC Share
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks. In addition, it offers diagnostic landscape, planning, implementation, and tracking services; and consulting services for precision medicine diagnostics. Further, the company provides test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training, and educational resources services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Company Data for DIACEUTICS PLC Share
Name DIACEUTICS PLC
Company Diaceutics PLC
Website https://www.diaceutics.com
Primary Exchange
London
WKN A2PF80
ISIN GB00BJQTGV64
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Mr. Ryan Keeling
Market Capitalization 107 Mio
Country United Kingdom
Currency GBP
Employees 0,2 T
Address Building Two, BT9 6GW Belfast
IPO Date 2019-03-21
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | 7DC.F |
London | DXRX.L |
More Shares
Investors who DIACEUTICS PLC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.